IBDEI0VA ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13928,1,4,0)
 ;;=4^T83.511S
 ;;^UTILITY(U,$J,358.3,13928,2)
 ;;=^5140140
 ;;^UTILITY(U,$J,358.3,13929,0)
 ;;=T83.512A^^83^818^54
 ;;^UTILITY(U,$J,358.3,13929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13929,1,3,0)
 ;;=3^Infection d/t Nephrostomy Catheter,Init Encntr
 ;;^UTILITY(U,$J,358.3,13929,1,4,0)
 ;;=4^T83.512A
 ;;^UTILITY(U,$J,358.3,13929,2)
 ;;=^5140141
 ;;^UTILITY(U,$J,358.3,13930,0)
 ;;=T83.512D^^83^818^56
 ;;^UTILITY(U,$J,358.3,13930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13930,1,3,0)
 ;;=3^Infection d/t Nephrostomy Catheter,Subs Encntr
 ;;^UTILITY(U,$J,358.3,13930,1,4,0)
 ;;=4^T83.512D
 ;;^UTILITY(U,$J,358.3,13930,2)
 ;;=^5140142
 ;;^UTILITY(U,$J,358.3,13931,0)
 ;;=T83.512S^^83^818^55
 ;;^UTILITY(U,$J,358.3,13931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13931,1,3,0)
 ;;=3^Infection d/t Nephrostomy Catheter,Sequela
 ;;^UTILITY(U,$J,358.3,13931,1,4,0)
 ;;=4^T83.512S
 ;;^UTILITY(U,$J,358.3,13931,2)
 ;;=^5140143
 ;;^UTILITY(U,$J,358.3,13932,0)
 ;;=R97.20^^83^818^28
 ;;^UTILITY(U,$J,358.3,13932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13932,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,13932,1,4,0)
 ;;=4^R97.20
 ;;^UTILITY(U,$J,358.3,13932,2)
 ;;=^334262
 ;;^UTILITY(U,$J,358.3,13933,0)
 ;;=R97.21^^83^818^29
 ;;^UTILITY(U,$J,358.3,13933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13933,1,3,0)
 ;;=3^Elevated PSA Following Trtmnt for Prostate Cancer
 ;;^UTILITY(U,$J,358.3,13933,1,4,0)
 ;;=4^R97.21
 ;;^UTILITY(U,$J,358.3,13933,2)
 ;;=^5139228
 ;;^UTILITY(U,$J,358.3,13934,0)
 ;;=N35.911^^83^818^109
 ;;^UTILITY(U,$J,358.3,13934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13934,1,3,0)
 ;;=3^Urethral Stricture,Male,Unspec
 ;;^UTILITY(U,$J,358.3,13934,1,4,0)
 ;;=4^N35.911
 ;;^UTILITY(U,$J,358.3,13934,2)
 ;;=^5157407
 ;;^UTILITY(U,$J,358.3,13935,0)
 ;;=N35.92^^83^818^108
 ;;^UTILITY(U,$J,358.3,13935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13935,1,3,0)
 ;;=3^Urethral Stricture,Female,Unspec
 ;;^UTILITY(U,$J,358.3,13935,1,4,0)
 ;;=4^N35.92
 ;;^UTILITY(U,$J,358.3,13935,2)
 ;;=^5157413
 ;;^UTILITY(U,$J,358.3,13936,0)
 ;;=A49.9^^83^819^1
 ;;^UTILITY(U,$J,358.3,13936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13936,1,3,0)
 ;;=3^Infection,Bacterial,Unspec
 ;;^UTILITY(U,$J,358.3,13936,1,4,0)
 ;;=4^A49.9
 ;;^UTILITY(U,$J,358.3,13936,2)
 ;;=^5000241
 ;;^UTILITY(U,$J,358.3,13937,0)
 ;;=B37.9^^83^819^2
 ;;^UTILITY(U,$J,358.3,13937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13937,1,3,0)
 ;;=3^Infection,Candidiasis,Unspec
 ;;^UTILITY(U,$J,358.3,13937,1,4,0)
 ;;=4^B37.9
 ;;^UTILITY(U,$J,358.3,13937,2)
 ;;=^5000624
 ;;^UTILITY(U,$J,358.3,13938,0)
 ;;=Z20.9^^83^819^3
 ;;^UTILITY(U,$J,358.3,13938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13938,1,3,0)
 ;;=3^Infection,Communicable Disease,Unspec
 ;;^UTILITY(U,$J,358.3,13938,1,4,0)
 ;;=4^Z20.9
 ;;^UTILITY(U,$J,358.3,13938,2)
 ;;=^5062776
 ;;^UTILITY(U,$J,358.3,13939,0)
 ;;=B30.9^^83^819^4
 ;;^UTILITY(U,$J,358.3,13939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13939,1,3,0)
 ;;=3^Infection,Conjunctivitis,Viral,Unspec
 ;;^UTILITY(U,$J,358.3,13939,1,4,0)
 ;;=4^B30.9
 ;;^UTILITY(U,$J,358.3,13939,2)
 ;;=^5000586
 ;;^UTILITY(U,$J,358.3,13940,0)
 ;;=B25.9^^83^819^5
 ;;^UTILITY(U,$J,358.3,13940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13940,1,3,0)
 ;;=3^Infection,Cytomegaloviral Disease,Unspec
 ;;^UTILITY(U,$J,358.3,13940,1,4,0)
 ;;=4^B25.9
